Veracyte | VCYT - EPS Earnings Per Share

Stock Price
38.48
Daily Change
-0.42 -1.08%
Monthly
16.50%
Yearly
31.78%
Q2 Forecast
37.71

Veracyte reported $0.52 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 0.52 0.34 0.31 May/05
FY2024Q4 Dec/2025 0.53 0.39 0.36 Feb/25
FY2025Q3 Sep/2025 0.51 0.32 0.33 Nov/04
FY2025Q2 Jun/2025 0.44 0.12 0.07 Aug/06
FY2025Q1 Mar/2025 0.31 0.02 -0.02 May/07




Eps Change Date
Agenus USD -0.3 0.84 Dec/2025
Agilent USD 1.32 0.35 Dec/2025
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD -0.93 1.15 Mar/2026
Bruker USD 0.31 0.28 Mar/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Illumina USD 1.15 0.2 Mar/2026
Intrexon USD -0.1 0.03 Jun/2024
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
Laboratory Of America USD 4.25 0.18 Mar/2026
Ligand Pharmaceuticals USD 1.63 0.39 Mar/2026
Myriad Genetics USD -0.09 0.13 Mar/2026
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Roche Holding CHF 8.37 2.95 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Siemens EUR 2.45 0.13 Mar/2026
Sonic Healthcare AUD 0.53 0.04 Dec/2025
Thermo Fisher Scientific USD 5.44 1.13 Mar/2026
Veracyte USD 0.52 0.01 Mar/2026
Waters USD 2.7 1.83 Mar/2026